Stockscreener 앱 받기
4.10
1.68%
-0.07
시간 외 거래:
4.10
전일 마감가:
$4.17
열려 있는:
$4.1
하루 거래량:
604.71K
Relative Volume:
0.60
시가총액:
$279.49M
수익:
-
순이익/손실:
$-27.03M
주가수익비율:
-7.3214
EPS:
-0.56
순현금흐름:
$-23.97M
1주 성능:
-12.95%
1개월 성능:
+6.22%
6개월 성능:
-23.51%
1년 성능:
+37.12%
1일 변동 폭
$3.96
$4.12
1주일 범위
$3.96
$4.76
52주 변동 폭
$2.54
$10.00
Corvus Pharmaceuticals Inc Stock (CRVS) Company Profile
명칭
Corvus Pharmaceuticals Inc
전화
(650) 900-4520
주소
863 MITTEN ROAD, BURLINGAME, CA
CRVS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CRVS
Corvus Pharmaceuticals Inc
|
4.10 | 321.57M | 0 | -27.03M | -23.97M | -0.56 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Corvus Pharmaceuticals Inc Stock (CRVS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-02 | 개시 | H.C. Wainwright | Buy |
| 2023-08-18 | 개시 | Oppenheimer | Outperform |
| 2021-12-01 | 재개 | Jefferies | Buy |
| 2021-05-27 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-02-10 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2019-09-12 | 개시 | Mizuho | Buy |
| 2019-05-29 | 개시 | ROTH Capital | Buy |
| 2017-08-24 | 업그레이드 | Credit Suisse | Underperform → Neutral |
| 2017-05-01 | 다운그레이드 | Credit Suisse | Neutral → Underperform |
| 2016-04-18 | 개시 | Credit Suisse | Outperform |
| 2016-04-18 | 개시 | Guggenheim | Buy |
모두보기
Corvus Pharmaceuticals Inc 주식(CRVS)의 최신 뉴스
What analysts say about Corvus Pharmaceuticals Inc. stockExceptional risk-adjusted gains - jammulinksnews.com
Is Corvus Pharmaceuticals Inc. a growth stock or a value stockBuild wealth faster with consistent investment plans - jammulinksnews.com
Does Corvus Pharmaceuticals Inc. stock perform well during market downturnsBuild wealth faster with high-performing stocks - jammulinksnews.com
Corvus Pharmaceuticals Inc. Stock Analysis and ForecastBuild a diversified portfolio for maximum returns - jammulinksnews.com
What are the latest earnings results for Corvus Pharmaceuticals Inc.Invest smarter with expert trading signals - jammulinksnews.com
What recovery options are there for Corvus Pharmaceuticals Inc.Free AI Powered High Return Stock Calls - Newser
Real time pattern detection on Corvus Pharmaceuticals Inc. stockFree Market Entry and Exit Point Tips - Newser
Smart tools for monitoring Corvus Pharmaceuticals Inc.’s price actionFree Alpha Driven Watchlist With Alerts - Newser
What makes Corvus Pharmaceuticals Inc. stock price move sharplyBreakout Stocks Watchlist That Work - jammulinksnews.com
Institutional scanner results for Corvus Pharmaceuticals Inc.Free Daily Stock Market Swing Alerts - Newser
Custom watchlist performance reports with Corvus Pharmaceuticals Inc.Safe Investment Ideas with Growth Upside - Newser
New Product Launches: Will They Boost Corvus Pharmaceuticals Inc. Stock in 2025Free Stock Portfolio Allocation Guidance - Newser
Applying chart zones and confluence areas to Corvus Pharmaceuticals Inc.Predictable Entry Strategy With Technical Backing - Newser
Can swing trading help recover from Corvus Pharmaceuticals Inc. lossesSafe Investment Ideas with Growth Upside - Newser
Corvus Pharmaceuticals to Provide Business Update and Second Quarter 2025 Financial Results on August 7, 2025 - The Manila Times
Clinical-Stage Biotech Corvus Pharmaceuticals Sets Q2 2025 Earnings Release: Key Updates Coming August 7 - Stock Titan
Price action breakdown for Corvus Pharmaceuticals Inc.AI Trade Signal Forecast with Chart Logic - Newser
Published on: 2025-07-30 23:35:48 - Newser
How Corvus Pharmaceuticals Inc. stock performs during market volatilityFree Reliable Alerts for Daily Stock Movers - Newser
Why Corvus Pharmaceuticals Inc. stock attracts strong analyst attentionReal Time Growth Signal with Smart Setup - Newser
Is Corvus Pharmaceuticals Inc. Stock a Smart Buy in 2025 Investment Analysis InsideWeekly Stock Watch With Growth Focus Expanded - metal.it
Quant Tools Rank Corvus Pharmaceuticals Inc. as High Risk High Reward - metal.it
How volatile is Corvus Pharmaceuticals Inc. stock compared to the marketInvest smarter with advanced market data - jammulinksnews.com
What are analysts’ price targets for Corvus Pharmaceuticals Inc. in the next 12 monthsLightning-fast capital gains - jammulinksnews.com
Screener Results Flag Corvus Pharmaceuticals Inc. as OversoldHigh Accuracy Alerts for ROI Traders Detected - beatles.ru
Is Corvus Pharmaceuticals Inc. stock overvalued or undervaluedPre Market Forecasts For 2025 - jammulinksnews.com
Is it the right time to buy Corvus Pharmaceuticals Inc. stockBreakthrough stock performance - jammulinksnews.com
Corvus Pharmaceuticals Inc. Company’s Quarterly Earnings Growth: What the Numbers SayReal Time Stock Signal - Newser
How does Corvus Pharmaceuticals Inc. generate profit in a changing economySuperior return velocity - jammulinksnews.com
Corvus Pharmaceuticals Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingFree Low-Risk Investment Plans - Newser
Is Corvus Pharmaceuticals Inc. stock a growth or value playRapid-fire capital growth - jammulinksnews.com
What drives Corvus Pharmaceuticals Inc. stock priceSuperior profit margins - PrintWeekIndia
Corvus Pharma Bets On Immunotherapy And Analyst Optimism - Finimize
Corvus Pharmaceuticals Inc (CRVS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.93%
0.15%
자본화:
|
볼륨(24시간):